AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

2021 Global Endocrine Function Testing Market Perspective - Competitive Shares and Growth Strategies - ResearchAndMarkets.com

July 22, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Jul 22, 2021--

The “2021 Global Endocrine Function Testing Market Perspective - US, Europe, Japan - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 20 Tests, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers” report has been added to ResearchAndMarkets.com’s offering.

This new report provides analysis of the endocrine function diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts, market shares and strategic profiles of leading suppliers.

ADVERTISEMENT

The report is available by section, and can be customized to specific information needs and budget.

The report provides test volume and sales forecasts for the following assays:

  • Cortisol
  • Estradiol
  • Follicle-Stimulating Hormone (FSH)
  • Gastrin
  • Growth Hormone/IGF-1
  • Human Chorionic Gonadotropin (HCG)
  • LH
  • Progesterone
  • PTH/IO PTH
  • Prolactin
  • T3
  • T3 Free
  • T3 Uptake
  • T4 (Thyroxine)
  • T4 Free
  • TBG
  • Testosterone
  • Thyroglobulin Ab
  • TPO Ab
  • TSH

Country Analyses

France, Germany, Italy, Japan, Spain, UK, US

During the next decade, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

This report is designed to help current suppliers and potential market entrants to identify and evaluate emerging opportunities and developed effective strategic responses.

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • bioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken Chemical
  • Fujirebio
  • Grifols
  • Instrumentation Laboratory/Werfen
  • Kyowa Medex
  • Ortho-Clinical Diagnostics
  • PerkinElmer
  • Quest Diagnostics
  • Roche
  • Siemens Healthineers
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako

ADVERTISEMENT

For more information about this report visit https://www.researchandmarkets.com/r/rr51co

View source version on businesswire.com:https://www.businesswire.com/news/home/20210722005695/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: GENERAL HEALTH HEALTH MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 07/22/2021 10:21 AM/DISC: 07/22/2021 10:22 AM

http://www.businesswire.com/news/home/20210722005695/en